Disease Studies

‘Digital Biomarkers’ session at BIO International Convention

8/06/20

Oxford, UK – PrecisionLife CEO Dr Steve Gardner will speak on the panel of today’s ‘Digital Biomarkers – a new dawn in CNS R&D’ to discuss how a stratified medicine approach using proprietary digital biomarkers optimised using AI/ML techniques could discover and validate new targets, as well as significantly reduce the risk of late-stage failure.

For more information please see www.bio.org/events/bio-digital/sessions/619255.


More News & Media

View All News & Media

Future of Precision Medicine Symposium

Copenhagen, 22-23 November 2021 Co-founders of PrecisionLife, Chief Executive Officer Steve Gardner, PhD and Chief Analytics Officer Gert L…

22/11/21
Read more

BioData World Congress 2021

Basel, 2-4 November 2021 PrecisionLife is attending the BioData World Congress 2021. The event is Europe’s largest congress covering…

22/10/21
Read more

BIO Europe 2021

Online, 25-28 October 2021 PrecisionLife is attending the international BIO Europe 2021 gathering alongside global biopharma and investment leaders…

22/10/21
Read more

Keep in touch

Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.

Contact us

If you have any questions or would like to speak to us in terms of potential collaborations or partnership opportunities, please get in touch using the form below or email info@precisionlife.com and we will get back to you as soon as we can. Note that our Privacy Policy and Terms & Conditions apply.


UK

Unit 8b Bankside
Hanborough Business Park
Long Hanborough, OX29 8LJ

USA

1 Broadway Fl 14
Cambridge
MA 02142-1187

Denmark

Agern Allé 3
DK-2970
Hørsholm

Poland

CIC Ul
Chmielna 73m
00-801 Warszawa